360 resultater (0,37744 sekunder)

Mærke

Butik

Pris (EUR)

Nulstil filter

Produkter
Fra
Butikker

Scientific Advances in Animal Nutrition - National Academy Of Sciences - Bog - National Academies Press - Plusbog.dk

Front-of-Package Nutrition Rating Systems and Symbols - Committee On Examination Of Front Of Package Nutrition Ratings Systems And Symbols - Bog -

DKK 305.00
3

Frontiers in the Nutrition Sciences - Institute Of Medicine - Bog - National Academies Press - Plusbog.dk

Advancing Nutrition and Food Science - Health And Medicine Division - Bog - National Academies Press - Plusbog.dk

Advancing Nutrition and Food Science - Health And Medicine Division - Bog - National Academies Press - Plusbog.dk

The Food and Nutrition Board (FNB) of the National Academies of Sciences, Engineering, and Medicine was convened in 1940 in response to a request from the U.S. National Defense Advisory Commission to the National Academy of Sciences for aid in studying problems of nutrition in the United States. Today the FNB is the focal point for activities concerned with food, nutrition, and food safety, and their roles in health maintenance and disease prevention. Now in its 80th year, the FNB has continued its growth and expanded its reach both domestically and internationally, providing visionary leadership across a range of nutrition and food science issues toward the improvement of human health. In honor of its 80 years of service to the nation, the FNB convened a public symposium to review the origin and history, policy influence, and future directions of the FNB. This publication summarizes the presentations of the event. Table of ContentsFront Matter1 Introduction2 Opening Remarks and Perspectives from Leadership3 Keynote Address4 The Food and Nutrition Board's Impact on Nutrition and Science: Domestic and International Perspectives5 New Challenges in Nutrition, Food Science, and Policy6 Participant Discussion: Future Directions for the Food and Nutrition Board7 Perspectives on the Future of the Food and Nutrition BoardReferencesAppendix A: Symposium AgendaAppendix B: Acronyms and AbbreviationsAppendix C: Biographical Sketches of Symposium Speakers and Moderators

DKK 344.00
3

Biomarker Tests for Molecularly Targeted Therapies - Institute Of Medicine - Bog - National Academies Press - Plusbog.dk

Biomarker Tests for Molecularly Targeted Therapies - Institute Of Medicine - Bog - National Academies Press - Plusbog.dk

Every patient is unique, and the evolving field of precision medicine aims to ensure the delivery of the right treatment to the right patient at the right time. In an era of rapid advances in biomedicine and enhanced understanding of the genetic basis of disease, health care providers increasingly have access to advanced technologies that may identify molecular variations specific to an individual patient, which subsequently can be targeted for treatment. Known as biomarker tests for molecularly targeted therapies, these complex tests have the potential to enable the selection of the most beneficial treatment (and also to identify treatments that may be harmful or ineffective) for the molecular underpinnings of an individual patient's disease. Such tests are key to unlocking the promise of precision medicine. Biomarker tests for molecularly targeted therapies represent a crucial area of focus for developing methods that could later be applicable to other areas of precision medicine. The appropriate regulatory oversight of these tests is required to ensure that they are accurate, reliable, properly validated, and appropriately implemented in clinical practice. Moreover, common evidentiary standards for assessing the beneficial impact of biomarker-guided therapy selection on patient outcomes, as well as the effective collection and sharing of information related to those outcomes, are urgently needed to better inform clinical decision making. Biomarker Tests of Molecularly Targeted Therapies examines opportunities for and challenges to the use of biomarker tests to select optimal therapy and offers recommendations to accelerate progress in this field. This report explores regulatory issues, reimbursement issues, and clinical practice issues related to the clinical development and use of biomarker tests for targeting therapies to patients. Properly validated, appropriately implemented biomarker tests hold the potential to enhance patient care and improve outcomes, and therefore addressing the challenges facing such tests is critical. Table of ContentsFront MatterSummary1 Introduction2 Envisioning a Rapid Learning System for Biomarker Tests for Molecularly Targeted Therapies3 Supportive Policy Environment for Biomarker Tests for Molecularly Targeted Therapies4 Supporting Data Infrastructure for Biomarker Tests for Molecularly Targeted Therapies5 Processes to Improve Patient CareAppendix A: Committee Member and Staff BiographiesAppendix B: Coding: Payment Infrastructure for Biomarker Tests for Molecularly Targeted TherapiesAppendix C: Information-Gathering Sessions and SpeakersGlossary

DKK 383.00
3

Nutrition and Traumatic Brain Injury - Trauma Committee On Nutrition - Bog - National Academies Press - Plusbog.dk

Use of Meta-Analyses in Nutrition Research and Policy - Health And Medicine Division - Bog - National Academies Press - Plusbog.dk

Nutrition During Pregnancy and Lactation - Health And Medicine Division - Bog - National Academies Press - Plusbog.dk

Nutrition During Pregnancy and Lactation - Health And Medicine Division - Bog - National Academies Press - Plusbog.dk

The National Academies of Sciences, Engineering, and Medicine last reviewed the state of the science on nutrition during pregnancy and lactation 30 years ago. The resulting consensus study reports from the Institute of Medicine—Nutrition During Pregnancy (IOM, 1990) and Nutrition During Lactation (IOM, 1991)—summarized the scientific evidence and provided nutrient recommendations. In the decades since the release of these two reports, the body of evidence on the relationships between nutrition during pregnancy and lactation and maternal and infant health and chronic disease has continued to grow and evolve. At the same time, the demographics of the population have shifted, giving rise to new considerations. To explore the evidence that has emerged, the National Academies conducted a 2-day workshop in January 2020. This publication summarizes the presentations and discussions from the workshop. Table of ContentsFront Matter1 Introduction2 Macronutrient Requirements3 One-Carbon Metabolism Micronutrients4 Iron, Vitamin D, Calcium, Antioxidants, and Iodine5 Dietary Supplements6 New Developments and Emerging Topics7 Maternal Intakes and Nutritional Status During Lactation and the Implications for Maternal and Infant Health8 Maternal Nutrient Intake and Early-Life Programming9 The Role of Systems and Policies in Providing Solutions to Nutrition Access and Equity During Pregnancy and Lactation10 Reflections on the WorkshopReferencesAppendix A: Acronyms and AbbreviationsAppendix B: Workshop AgendaAppendix C: Biographical Sketches of Workshop Speakers and Moderators

DKK 370.00
3